35 | Peptides (Polypeptides)IBA
01/2021
-
02/2002 |
22 | alpha-MSHIBA
01/2020
-
02/2002 |
13 | Radioisotopes (Radionuclides)IBA
01/2021
-
02/2002 |
12 | Type 1 Melanocortin ReceptorIBA
01/2021
-
11/2003 |
9 | RadiopharmaceuticalsIBA
01/2021
-
07/2002 |
9 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2019
-
02/2002 |
7 | Silicon Dioxide (Silica)FDA LinkGeneric
08/2020
-
02/2018 |
7 | Biomarkers (Surrogate Marker)IBA
01/2020
-
10/2005 |
6 | AntigensIBA
11/2019
-
02/2003 |
5 | Melanocyte-Stimulating Hormones (MSH)IBA
08/2020
-
01/2014 |
5 | LigandsIBA
12/2019
-
01/2015 |
5 | Chelating AgentsIBA
09/2017
-
05/2009 |
5 | AcidsIBA
12/2010
-
08/2005 |
5 | RheniumIBA
07/2009
-
02/2002 |
4 | Thomsen-Friedenreich antigenIBA
11/2011
-
02/2003 |
3 | Proteins (Proteins, Gene)FDA Link
11/2021
-
10/2005 |
3 | Pharmaceutical PreparationsIBA
08/2021
-
10/2018 |
3 | LactamsIBA
01/2017
-
02/2008 |
3 | CarbohydratesIBA
11/2011
-
10/2005 |
3 | MetalsIBA
05/2009
-
02/2002 |
2 | Monoclonal AntibodiesIBA
12/2017
-
10/2012 |
2 | Epidermal Growth Factor (EGF)IBA
10/2012
-
12/2010 |
2 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
10/2012
-
12/2010 |
2 | StreptavidinIBA
10/2009
-
03/2007 |
2 | Biotin (Vitamin H)FDA Link
10/2009
-
10/2007 |
2 | Lysine (L-Lysine)FDA Link
11/2007
-
10/2002 |
2 | ErbB-2 ReceptorIBA
10/2007
-
05/2002 |
2 | Therapeutic UsesIBA
06/2007
-
01/2005 |
2 | 1,4,7,10-tetraazacyclododecane 1,4,7,10-tetraacetic acid (ReO- acetyl(Cys(3,4,10),Phe(7),Arg(7))alpha- MSH(3- 13))IBA
01/2007
-
04/2005 |
2 | Amino AcidsFDA Link
08/2006
-
10/2002 |
1 | Antiviral Agents (Antivirals)IBA
04/2021 |
1 | Anti-Bacterial Agents (Antibiotics)IBA
01/2021 |
1 | Succinic Acid (Succinate)IBA
01/2021 |
1 | Integrin alpha4beta1 (VLA-4)IBA
01/2021 |
1 | IntegrinsIBA
01/2021 |
1 | Dietary FiberFDA Link
01/2021 |
1 | Actinium-225IBA
08/2020 |
1 | Antineoplastic Agents (Antineoplastics)IBA
08/2020 |
1 | VaccinesIBA
04/2020 |
1 | 4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA
01/2020 |
1 | Lutetium-177IBA
01/2020 |
1 | Biological ProductsIBA
01/2020 |
1 | Cyclic PeptidesIBA
01/2020 |
1 | Phenobarbital (Luminal)FDA Link
01/2020 |
1 | MicroRNAs (MicroRNA)IBA
12/2019 |
1 | Messenger RNA (mRNA)IBA
12/2019 |
1 | Coloring Agents (Dyes)IBA
11/2019 |
1 | Histone Deacetylase InhibitorsIBA
01/2019 |
1 | Single-Chain AntibodiesIBA
10/2018 |
1 | Immunoglobulin FragmentsIBA
10/2018 |
1 | human ERBB2 proteinIBA
10/2018 |
1 | cyanine dye 5IBA
02/2018 |
1 | Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
02/2018 |
1 | procaine isothiocyanate (PRIT)IBA
12/2017 |
1 | Aminocaproic Acid (6 Aminocaproic Acid)FDA LinkGeneric
01/2017 |
1 | hexanoic acid (hexanoate)IBA
01/2017 |
1 | tricineIBA
01/2015 |
1 | EDDA (NiEDDA)IBA
01/2015 |
1 | dioxotechnetiumIBA
01/2014 |
1 | MelanocortinsIBA
10/2012 |
1 | Copper-62IBA
10/2012 |
1 | nimotuzumabIBA
10/2012 |
1 | DisaccharidesIBA
11/2011 |
1 | AcetylgalactosamineIBA
11/2011 |
1 | Galactose (Galactopyranose)FDA LinkGeneric
11/2011 |
1 | triazacyclononaneIBA
12/2010 |
1 | n-hexadecaneIBA
12/2010 |
1 | CopperIBA
05/2009 |
1 | Ceruloplasmin (Ferroxidase)IBA
05/2009 |
1 | EnzymesIBA
05/2009 |
1 | Copper-Transporting ATPasesIBA
05/2009 |
1 | N- (2- aminoethyl)- 1,2- diaminocyclohexane- N,N',N''- pentaacetic acid-Re(Cys(3,4,10))-Phe(7)-Arg(11)- alpha-MSH(3-13)IBA
05/2009 |
1 | Superoxide DismutaseIBA
05/2009 |
1 | N- (2- amino- 3- (4- isothiocyanatophenyl)propyl)cyclohexane- 1,2- diamine- N,N',N',N'',N''- pentaacetic acidIBA
05/2009 |
1 | Electron Transport Complex IV (Cytochrome c Oxidase)IBA
05/2009 |
1 | Melanins (Melanin)IBA
09/2008 |
1 | N-glycylglutamic acidIBA
02/2008 |
1 | Cytotoxins (Cytolysins)IBA
10/2007 |